Tom
If you have a look at Solbec's Development Strategy, they are targeting both Mesothelioma & Melanoma (both relatively low-incidence cancers) in achieving Orphan Drug approval.
It was very interesting to see Progen has achieved OD approval only 3 months after commencing Phase 11 trials......
SBP
solbec pharmaceuticals limited
progen granted orphan drug status, page-7
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)